This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Academia Sinica, National Taiwan University. Active years: 2015-2016.
Company Filing History:
2 out of 726 
2 out of 1,391 
Years Active: 2015-2016
Title: Ching-Chow Chen: Innovator in Pharmaceutical Compounds
Introduction
Ching-Chow Chen is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target critical enzymes involved in various diseases. With a total of 2 patents, his work has the potential to impact the treatment of serious health conditions.
Latest Patents
Chen's latest patents include "3,5,N-trihydroxy-alkanamide and derivatives: method for making same and use thereof" and "Dual action inhibitors against histone deacetylases and 3-hydroxy-3-methylglutaryl coenzyme A reductase." The first patent presents novel compounds that serve as inhibitors of histone deacetylases (HDACs) and 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase (HMGR). These compounds are designed to treat diseases associated with HDACs or HMGR, including cancer and hypercholesterolemia. The second patent also focuses on similar compounds and their applications in treating various diseases, including autoimmune and neurodegenerative diseases.
Career Highlights
Ching-Chow Chen has worked at prestigious institutions such as Academia Sinica and National Taiwan University. His research has been pivotal in advancing the understanding of enzyme inhibitors and their therapeutic applications.
Collaborations
Throughout his career, Chen has collaborated with notable colleagues, including Jung-Hsin Lin and Jim-Min Fang. These partnerships have fostered innovation and contributed to the success of his research endeavors.
Conclusion
Ching-Chow Chen's work in developing pharmaceutical compounds showcases his dedication to addressing critical health issues through innovative solutions. His patents reflect a commitment to advancing medical science and improving patient outcomes.